Mobia Medical Reports 73% Revenue Growth and Raises Full Year 2026 Guidance
Mobia Medical (MOBI) reported strong third-quarter 2026 financial results, highlighted by a 73% year-over-year revenue increase to $15.6 million. This growth was primarily driven by the widespread adoption of the Vivistim System and an expansion of active sales territories, which grew from 22.5 to 40 compared to the previous year. Following robust commercial execution, the company raised its full-year 2026 revenue guidance to a range of $57.0 million to $57.5 million. While operating expenses rose due to increased headcount and sales commissions, gross margins improved to 83.2%. The company also noted a significant clinical milestone as the American Heart Association updated its stroke recovery guidelines to include paired vagus nerve stimulation.
Tickers: $MOBI
Topics: Gross Margin Improvement Guidance Raise Revenue Growth Vivistim System Sales